Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...

By mode of administration, the injectable pens segment accounted for the highest revenue-grossing segment ... For instance, ...